Cercar
18/08/2025
Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance
Ruiz-Ramos, J. Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance. Antibiotics-Basel. 2025; 14(8)DOI:10.3390/antibiotics14080835. PMID:40868029. IF:4.600(Q1/2D).
08/08/2025
The Role of Pharmacogenetic Biomarkers in Pain
da Silva, IM, Plaza-Díaz, A, Ruiz-Ramos, J, Juanes-Borrego, A, Riera, P. The Role of Pharmacogenetic Biomarkers in Pain. Biomedicines. 2025; 13(8)DOI:10.3390/biomedicines13081935. PMID:40868188. IF:3.900(Q1/3D).
01/07/2025
Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to ß-blockers: A double-blind, placebo-controlled, randomized trial
Alvarado-Tapias, E, Brujats, A, Puente, A, Ardevol, A, Rodriguez-Arias, A, Fajardo, J, Pavel, O, Garcia-Guix, M, Aracil, C, Poca, M, Cuyàs, B, Cantó, E, Montañés, R, Garcia-Osuna, A, Escorsell, A, Torras, X, Villanueva, C. Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to ß-blockers: A double-blind, placebo-controlled, randomized trial. HEPATOLOGY. 2025; 82(1)DOI:10.1097/HEP.0000000000001148. PMID:39509369. IF:15.800(Q1/1D).
01/07/2025
Successful implementation of a bundle to prevent increased excessive-spectrum antimicrobial use under new EUCAST susceptibility definitions: a quasi-experimental study in a tertiary hospital
Duch-Llorach, P, Simonetti, AF, Figueras-Roig, A, Rivera, A, de Gamarra-Martínez, EF, Gras-Martin, L, Moreno-Martinez, ME, Ramos, JR, Zarate-Tamames, B, Navarro, F, López-Contreras, J, Escolà-Vergé, L. Successful implementation of a bundle to prevent increased excessive-spectrum antimicrobial use under new EUCAST susceptibility definitions: a quasi-experimental study in a tertiary hospital. JOURNAL OF HOSPITAL INFECTION. 2025; 161DOI:10.1016/j.jhin.2025.04.016. PMID:40306370. IF:3.100(Q1/3D).
01/05/2025
Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy
Colominas-Gonzalez, E, De Antonio, M, Masip, M, Conde, MTM, Cardona, G, Restituto, DF, Comas, D, Roch, MA, Lopez, B, Torres-Bondia, FI, Retamero, A, Knobel, H, Luque, S. Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy. EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2025; 32(3)DOI:10.1136/ejhpharm-2024-004118. PMID:38802166. IF:1.500(Q4/8D).
17/04/2025
HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+lymphoma
Caballero, AC, Ujaldón-Miró, C, Pujol-Fernández, P, Montserrat-Torres, R, Guardiola-Perello, M, Escudero-López, E, Garcia-Cadenas, I, Esquirol, A, Martino, R, Jara-Bustamante, P, Ezquerra, P, Soria, JM, Iranzo, E, Moreno-Martinez, ME, Riba, M, Sierra, J, Alvarez-Fernández, C, Escribà-Garcia, L, Briones, J. HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+lymphoma. BLOOD. 2025; 145(16)DOI:10.1182/blood.2024026758. PMID:39841453. IF:23.100(Q1/1D).